[A device for fluorescence diagnosis and photodynamic therapy of eye diseases, by using photosense]

Скачать 217.57 Kb.
Название[A device for fluorescence diagnosis and photodynamic therapy of eye diseases, by using photosense]
Размер217.57 Kb.
1   2   3   4   5   6   7   8
Genes Dev 19 (1): 176-187, 2005

Faybush EM; Sampliner RE. Randomized trials in the treatment of Barrett's esophagus. Dis Esophagus 18 (5): 291-297, 2005

Feigl B; Lovie-Kitchin J; Brown B. Objective functional assessment of age-related maculopathy: a special application for the multifocal electroretinogram. Clin Exp Optom 88 (5): 304-312, 2005

Fergin P. Photodynamic therapy of dermatoses other than non-melanoma skin cancer. Australas J Dermatol 46 Suppl: S27, 2005

Ferrario A; Fisher AM; Rucker N; Gomer CJ. Celecoxib and NS-398 enhance photodynamic therapy by increasing in vitro apoptosis and decreasing in vivo inflammatory and angiogenic factors. Cancer Res 65 (20): 9473-9478, 2005

Figurska M; Stankiewicz A. [Therapy of the wet form of age-related macular disease: the present state and perspectives]. Klin Oczna 107 (4-6): 334-339, 2005

Fine SL. Age-related macular degeneration 1969-2004: a 35-year personal perspective. Am J Ophthalmol 139 (3): 405-420, 2005

Finlan LE; Kernohan NM; Thomson G; Beattie PE; Hupp TR; Ibbotson SH. Differential effects of 5-aminolaevulinic acid photodynamic therapy and psoralen + ultraviolet A therapy on p53 phosphorylation in normal human skin in vivo. Br J Dermatol 153 (5): 1001-1010, 2005

Foley P. Clinical efficacy of methyl aminolaevulinate photodynamic therapy in basal cell carcinoma and solar keratosis. Australas J Dermatol 46 Suppl: S8-10, 2005

Foley P. Methyl aminolaevulinate photodynamic therapy in practice: treatment protocol. Australas J Dermatol 46 Suppl: S14-S15, 2005

Foley P. Practical aspects of methyl aminolaevulinate photodynamic therapy. Australas J Dermatol 46 Suppl: S12-S13, 2005

Foster TH; Pearson BD; Mitra S; Bigelow CE. Fluorescence Anisotropy Imaging Reveals Localization of meso-Tetrahydroxyphenyl Chlorin in the Nuclear Envelope. Photochem Photobiol , 2005

Foy RC; Foot B; Francis J; Chakravarthy U; Wormald RP. Trends in provision of photodynamic therapy and clinician attitudes: a tracker survey of a new health technology. BMC Health Serv Res 5 (1): 34, 2005

Fukuda H; Casas A; Batlle A. Aminolevulinic acid: from its unique biological function to its star role in photodynamic therapy. Int J Biochem Cell Biol 37 (2): 272-276, 2005

Furukawa K; Kato H; Konaka C; Okunaka T; Usuda J; Ebihara Y. Locally Recurrent Central-Type Early Stage Lung Cancer < 1.0 cm in Diameter After Complete Remission by Photodynamic Therapy. Chest 128 (5): 3269-3275, 2005

Gabel-Pfisterer A; Wehner A; Heimann H; Foerster MH; Wachtlin J. [Photodynamic therapy with verteporfin for recurrent choroidal neovascularisation (CNV) following prior argon laser coagulation]. Ophthalmologe 102 (6): 592-596, 2005

Galaz S; Espada J; Stockert JC; Pacheco M; Sanz-Rodriguez F; Arranz R; Rello S; Canete M; Villanueva A; Esteller M; Juarranz A. Loss of E-cadherin mediated cell-cell adhesion as an early trigger of apoptosis induced by photodynamic treatment. J Cell Physiol 205 (1): 86-96, 2005

Gallagher WM; Allen LT; O'Shea C; Kenna T; Hall M; Gorman A; Killoran J; O'shea DF. A potent nonporphyrin class of photodynamic therapeutic agent: cellular localisation, cytotoxic potential and influence of hypoxia. Br J Cancer 92 (9): 1702-1710, 2005

Gandorfer A; Haritoglou C; Priglinger S. [Age-related macular degeneration]. MMW Fortschr Med 147 (21): 35-38, 2005

Ganz RA. Photodynamic therapy is nonthermal injury. Gastrointest Endosc 62 (5): 820, 2005

Garcia-Zuazaga J; Cooper KD; Baron ED. Photodynamic therapy in dermatology: current concepts in the treatment of skin cancer. Expert Rev Anticancer Ther 5 (5): 791-800, 2005

Gebka A; Raczynska K; Ciechanowski C; Krajka-Lauer J. [Photodynamic therapy with verteporfin in treating the choroidal neovascularisation secondary to multifocal choroiditis]. Klin Oczna 107 (1-3): 118-120, 2005

Gederaas OA; Schonberg SA; Ramstad S; Berg K; Johnsson A; Krokan HE. Cell specific effects of polyunsaturated fatty acids on 5-aminolevulinic acid based photosensitization. Photochem Photobiol Sci 4 (4): 383-389, 2005

Gelisken F; Inhoffen W; Karim-Zoda K; Grisanti S; Partsch M; Voelker M; Bartz-Schmidt KU. Subfoveal hemorrhage after verteporfin photodynamic therapy in treatment of choroidal neovascularization. Graefes Arch Clin Exp Ophthalmol 243 (3): 198-203, 2005

George JE, III; Ahmad Y; Varghai D; Li X; Berlin J; Jackowe D; Jungermann M; Wolfe MS; Lilge L; Totonchi A; Morris RL; Peterson A; Lust WD; Kenney ME; Hoppel CL; Sun J; Oleinick NL; Dean D. Pc 4 photodynamic therapy of U87-derived human glioma in the nude rat. Lasers Surg Med 36 (5): 383-389, 2005

Giansanti F; Virgili G; Varano M; Tedeschi M; Rapizzi E; Giacomelli G; Menchini U. Photodynamic therapy for choroidal neovascularization in pediatric patients. Retina 25 (5): 590-596, 2005

Gibson J. Photodynamic therapy with verteporfin for juxtafoveal choroidal neovascularisation secondary to pathological myopia. Eye 19 (8): 829-830, 2005

Gilbert DJ. Treatment of actinic keratoses with sequential combination of 5-fluorouracil and photodynamic therapy. J Drugs Dermatol 4 (2): 161-163, 2005

Gillies ER; Frechet JM. Dendrimers and dendritic polymers in drug delivery. Drug Discov Today 10 (1): 35-43, 2005

Goel M; Damai RS; Sethi DK; Kaur KJ; Maiya BG; Swamy MJ; Salunke DM. Crystal structures of the PNA-porphyrin complex in the presence and absence of lactose: mapping the conformational changes on lactose binding, interacting surfaces, and supramolecular aggregations. Biochemistry 44 (15): 5588-5596, 2005

Goldman MP; Weiss RA; Weiss MA. Intense pulsed light as a nonablative approach to photoaging. Dermatol Surg 31 (9 Pt 2): 1179-1187, 2005

Goldstein M; Heilweil G; Barak A; Loewenstein A. Retinal pigment epithelial tear following photodynamic therapy for choroidal neovascularization secondary to AMD. Eye , 2005

Golshevsky JR; O'Day J. Photodynamic therapy in the management of juxtapapillary capillary haemangiomas. Clin Experiment Ophthalmol 33 (5): 509-512, 2005

Gomes AJ; Lunardi LO; Marchetti JM; Lunardi CN; Tedesco AC. Photobiological and ultrastructural studies of nanoparticles of poly(lactic-co-glycolic acid)-containing bacteriochlorophyll-a as a photosensitizer useful for PDT treatment. Drug Deliv 12 (3): 159-164, 2005

Gu H; Xu K; Yang Z; Chang CK; Xu B. Synthesis and cellular uptake of porphyrin decorated iron oxide nanoparticles-a potential candidate for bimodal anticancer therapy. Chem Commun (Camb ) (34): 4270-4272, 2005

Gupta R; Browning AC; Wu K; Sokal M; Amoaku WM. Verteporfin photodynamic therapy for the treatment of persistent subfoveal choroidal neovascularization after external beam radiotherapy: one-year results. Am J Ophthalmol 139 (3): 561-562, 2005

Gustavsson C; Agardh E. Transpupillary thermotherapy for occult subfoveal choroidal neovascularization: a 1-year, prospective randomized pilot study. Acta Ophthalmol Scand 83 (2): 148-153, 2005

Hage M; Siersema PD; Vissers KJ; Steyerberg EW; Haringsma J; Kuipers EJ; van Dekken H. Molecular evaluation of ablative therapy of Barrett's oesophagus. J Pathol 205 (1): 57-64, 2005

Hamblin MR; Viveiros J; Yang C; Ahmadi A; Ganz RA; Tolkoff MJ. Helicobacter pylori accumulates photoactive porphyrins and is killed by visible light. Antimicrob Agents Chemother 49 (7): 2822-2827, 2005

Hamzavi I; Lui H. Using light in dermatology: an update on lasers, ultraviolet phototherapy, and photodynamic therapy. Dermatol Clin 23 (2): 199-207, 2005

Hanai H; Iida T; Takeuchi K; Watanabe F; Maruyama Y; Kikuyama M; Tanaka T; Kondo K; Tanaka K; Takai K. Decrease of reactive-oxygen-producing granulocytes and release of IL-10 into the peripheral blood following leukocytapheresis in patients with active ulcerative colitis. World J Gastroenterol 11 (20): 3085-3090, 2005

Harada M; Woodhams J; Macrobert AJ; Feneley MR; Kato H; Bown SG. The vascular response to photodynamic therapy with ATX-S10Na(II) in the normal rat colon. J Photochem Photobiol B 79 (3): 223-230, 2005

Harewood GC; Baron TH; Rumalla A; Wang KK; Gores GJ; Stadheim LM; de Groen PC. Pilot study to assess patient outcomes following endoscopic application of photodynamic therapy for advanced cholangiocarcinoma. J Gastroenterol Hepatol 20 (3): 415-420, 2005

Hariprasad SM; Shah GK. Treatment of juxtafoveal choroidal neovascularization with photodynamic therapy using verteporfin in eyes with age-related macular degeneration. Ophthalmic Surg Lasers Imaging 36 (3): 258-260, 2005

Harissi-Dagher M; Sebag M; Gauthier D; Marcil G; Labelle P; Arbour JD. Photodynamic therapy in young patients with choroidal neovascularization following traumatic choroidal rupture. Am J Ophthalmol 139 (4): 726-728, 2005

Harris F; Chatfield LK; Phoenix DA. Phenothiazinium based photosensitisers--photodynamic agents with a multiplicity of cellular targets and clinical applications. Curr Drug Targets 6 (5): 615-627, 2005

Harvey EH; Webber J; Kessel D; Fromm D. Killing tumor cells: the effect of photodynamic therapy using mono-L-aspartyl chlorine and NS-398. Am J Surg 189 (3): 302-305, 2005

Hauschild A; Lischner S; Lange-Asschenfeldt B; Egberts F. Treatment of actinic cheilitis using photodynamic therapy with methylaminolevulinate: report of three cases. Dermatol Surg 31 (10): 1344-7, discussion, 2005

Hawkins D; Abrahamse H. Biological effects of helium-neon laser irradiation on normal and wounded human skin fibroblasts. Photomed Laser Surg 23 (3): 251-259, 2005

Hayek RR; Araujo NS; Gioso MA; Ferreira J; Baptista-Sobrinho CA; Yamada AM; Ribeiro MS. Comparative study between the effects of photodynamic therapy and conventional therapy on microbial reduction in ligature-induced peri-implantitis in dogs. J Periodontol 76 (8): 1275-1281, 2005

Haywood-Small SL; Vernon DI; Griffiths J; Schofield J; Brown SB. Phthalocyanine-mediated photodynamic therapy induces cell death and a G(0)/G(1) cell cycle arrest in cervical cancer cells. Biochem Biophys Res Commun , 2005

He SZ; Wei WB. [Effects of surgical treatment for choroidal neovascularization in age-related macular degeneration needs further evaluation]. Zhonghua Yan Ke Za Zhi 41 (4): 292-294, 2005

Heimann H; Gelisken F; Wachtlin J; Wehner A; Volker M; Foerster MH; Bartz-Schmidt KU. Photodynamic therapy with verteporfin for choroidal neovascularisation associated with angioid streaks. Graefes Arch Clin Exp Ophthalmol , 2005

Hendrickx N; Dewaele M; Buytaert E; Marsboom G; Janssens S; Van Boven M; Vandenheede JR; de Witte P; Agostinis P. Targeted inhibition of p38alpha MAPK suppresses tumor-associated endothelial cell migration in response to hypericin-based photodynamic therapy. Biochem Biophys Res Commun 337 (3): 928-935, 2005

Hillemanns P; Wang X; Staehle S; Michels W; Dannecker C. Evaluation of different treatment modalities for vulvar intraepithelial neoplasia (VIN): CO(2) laser vaporization, photodynamic therapy, excision and vulvectomy. Gynecol Oncol , 2005

Hirst LW. Treatment of conjunctival squamous cell carcinoma with photodynamic therapy. Am J Ophthalmol 139 (4): 759-760, 2005

Hjelde A; Gederaas OA; Krokan HE; Brubakk AO. Lack of effect of hyperoxia on photodynamic therapy and lipid peroxidation in three different cancer cell lines. Med Sci Monit 11 (10): BR351-BR356, 2005

Hogan A; Behan U; Kilmartin DJ. Outcomes after combination photodynamic therapy and immunosuppression for inflammatory subfoveal choroidal neovascularisation. Br J Ophthalmol 89 (9): 1109-1111, 2005

Hogan AC; Kilmartin DJ. Low power vs standard power transpupillary thermotherapy in patients with age-related macular degeneration and subfoveal choroidal neovascularization ineligible for photodynamic therapy. Eye , 2005

Homs MY; Kuipers EJ; Siersema PD. Palliative therapy. J Surg Oncol 92 (3): 246-256, 2005

Hu X; Feng Y; Lu JQ; Allison RR; Cuenca RE; Downie GH; Sibata CH. Modeling of a Type II Photofrin-Mediated Photodynamic Therapy Process in a Heterogeneous Tissue Phantom. Photochem Photobiol , 2005

Huang HF; Chen YZ; Wu Y. Experimental studies of the effects of ZnPcS2P2-based-photodynamic therapy on bone marrow purging. Chin Med J (Engl ) 118 (2): 105-110, 2005

Huang HF; Chen YZ; Wu Y. Mitochondria-dependent apoptosis induced by a novel amphipathic photochemotherapeutic agent ZnPcS2P2 in HL60 cells. Acta Pharmacol Sin 26 (9): 1138-1144, 2005

Huang HF; Chen YZ; Wu Y; Chen P. Purging of murine erythroblastic leukemia by ZnPcS(2)P(2)-based-photodynamic therapy. Bone Marrow Transplant , 2005

Huang HF; Chen YZ; Wu Y. ZnPcS2P2-based photodynamic therapy induces mitochondria-dependent apoptosis in K562 cells. Acta Biochim Biophys Sin (Shanghai) 37 (7): 488-494, 2005

Huang Z. A review of progress in clinical photodynamic therapy. Technol Cancer Res Treat 4 (3): 283-293, 2005

Huang Z; Chen Q; Luck D; Beckers J; Wilson BC; Trncic N; Larue SM; Blanc D; Hetzel FW. Studies of a vascular-acting photosensitizer, Pd-bacteriopheophorbide (Tookad), in normal canine prostate and spontaneous canine prostate cancer. Lasers Surg Med 36 (5): 390-397, 2005

Hudson R; Carcenac M; Smith K; Madden L; Clarke OJ; Pelegrin A; Greenman J; Boyle RW. The development and characterisation of porphyrin isothiocyanate-monoclonal antibody conjugates for photoimmunotherapy. Br J Cancer 92 (8): 1442-1449, 2005

Hueber A; Grisanti S; Diestelhorst M. Photodynamic therapy for wound-healing modulation in pterygium surgery. A clinical pilot study. Graefes Arch Clin Exp Ophthalmol 243 (9): 942-946, 2005

Hughes EH; Khan J; Patel N; Kashani S; Chong NV. In vivo demonstration of the anatomic differences between classic and occult choroidal neovascularization using optical coherence tomography. Am J Ophthalmol 139 (2): 344-346, 2005

Huiskamp EA; Muskens RP; Ballast A; Hooymans JM. Diffuse choroidal haemangioma in Sturge-Weber syndrome treated with photodynamic therapy under general anaesthesia. Graefes Arch Clin Exp Ophthalmol 243 (7): 727-730, 2005

Hunter GA; Rivera E; Ferreira GC. Supraphysiological concentrations of 5-aminolevulinic acid dimerize in solution to produce superoxide radical anions via a protonated dihydropyrazine intermediate. Arch Biochem Biophys 437 (2): 128-137, 2005

Hur C; Wittenberg E; Nishioka NS; Gazelle GS. Patient preferences for the management of high-grade dysplasia in Barrett's esophagus. Dig Dis Sci 50 (1): 116-125, 2005

Husain D; Kim I; Gauthier D; Lane AM; Tsilimbaris MK; Ezra E; Connolly EJ; Michaud N; Gragoudas ES; O'Neill CA; Beyer JC; Miller JW. Safety and efficacy of intravitreal injection of ranibizumab in combination with verteporfin PDT on experimental choroidal neovascularization in the monkey. Arch Ophthalmol 123 (4): 509-516, 2005

Hussain N; Das T; Sumasri K; Ram LS. Bilateral sequential photodynamic therapy for sub-retinal neovascularization with type 2A parafoveal telangiectasis. Am J Ophthalmol 140 (2): 333-335, 2005

Hussain N; Hussain A; Natarajan S. Role of photodynamic therapy in polypoidal choroidal vasculopathy. Indian J Ophthalmol 53 (2): 101-104, 2005

Huygens A; Kamuhabwa AR; Van Laethem A; Roskams T; Van Cleynenbreugel B; Van Poppel H; Agostinis P; de Witte PA. Enhancing the photodynamic effect of hypericin in tumour spheroids by fractionated light delivery in combination with hyperoxygenation.
1   2   3   4   5   6   7   8


[A device for fluorescence diagnosis and photodynamic therapy of eye diseases, by using photosense] iconSelected Anomalies and Diseases of the Eye

[A device for fluorescence diagnosis and photodynamic therapy of eye diseases, by using photosense] iconHepatic Liver Diseases – Methods for Diagnosis and

[A device for fluorescence diagnosis and photodynamic therapy of eye diseases, by using photosense] iconAbengoechea-hernandez, S., Elizalde-montagut, J. & Fideliz de la paz-dalisay, M. (2007) [Photodynamic therapy in adult-onset foveomacular vitelliform

[A device for fluorescence diagnosis and photodynamic therapy of eye diseases, by using photosense] iconБад «нагипол» в терапии алиментарно-зависимых патологий. Baa "nagipol" in therapy alimentary-dependent’s diseases
Ключевые слова: биологически-активная добавка (бад), пивные дрожжи, автолизат, алиментарно-зависимые патологии, витамины, аминокислоты,...
[A device for fluorescence diagnosis and photodynamic therapy of eye diseases, by using photosense] iconEndometriosis. Gynaecological diseases of children and teenagers
[A device for fluorescence diagnosis and photodynamic therapy of eye diseases, by using photosense] iconSession 2: Fourier Transform Infrared (ft ir) & Fluorescence Spectroscopy

[A device for fluorescence diagnosis and photodynamic therapy of eye diseases, by using photosense] iconThe American Occupational Therapy Foundation & American Occupational Therapy Association’s

[A device for fluorescence diagnosis and photodynamic therapy of eye diseases, by using photosense] icon2. Device choice

[A device for fluorescence diagnosis and photodynamic therapy of eye diseases, by using photosense] icon“Assistive Device for Calendar Production”

[A device for fluorescence diagnosis and photodynamic therapy of eye diseases, by using photosense] iconEye Tracking and e-Learning

Разместите кнопку на своём сайте:

База данных защищена авторским правом ©lib.znate.ru 2014
обратиться к администрации
Главная страница